Myriad Investor Day 2023 replay is now available. Watch now
Request more information or explore ordering options to bring MyRisk hereditary cancer testing to your practice.
Fill in your information below and we’ll send you an email with more information
By sharing your healthcare provider’s information, we can provide them with more education and information about hereditary cancer testing.
With the right hereditary cancer test, you can uncover valuable insights and answers that empower you and your patient to do more to help prevent cancer or diagnose it at an earlier, more treatable stage.
MyRisk® Hereditary Cancer Test results, whether negative, positive, or elevated, can be used to your patients’ benefit. Combined with their personal and family history of cancer, the report will provide you with valuable information to effectively make decisions and manage patient cancer risk on an individual basis.
MyRisk with RiskScore® is a powerful tool that evaluates 48 genes associated with 11 different hereditary cancers. MyRisk helps any practice easily assess a patient’s lifetime hereditary cancer risk and help improve patient outcomes with expert guidance, support, and personalized care plans.
Designed for patients of all ancestries, RiskScore is a component of the MyRisk test that analyzes family history, personal clinical risk factors, and genetic markers to estimate the risk of developing breast cancer over the next five years and remaining lifetime.
Our decades of genetic testing experience help you make confident and informed decisions with your patients. We provide personalized care plans based on each patient’s unique risk profile, and our team of experts is here to support you and your patient every step of the way.
We support patients and healthcare providers throughout the genetic testing process through pre-test education, transparent pricing and financial support, clear results reporting, and post-test education.
These solutions allow for simple integration of Myriad’s tests into routine clinical care and help patients better understand and benefit from their results.
Lisa’s mom’s battle with breast cancer inspired her to get genetic testing and make a life-saving choice. Her story is a testament to courage and resilience.
Cost should never be a barrier when your patients need genetic testing to determine their risk reduction plan. It’s our promise to make testing accessible and affordable through options including:
Myriad’s Financial Assistance Program (MFAP) can help if your patients have a high deductible or co-insurance. With MFAP, they may qualify for $0 or reduced out-of-pocket cost, dependent on family size and income.
Myriad Promise is our commitment to provide patients with access to accurate and affordable genetic results.